Born in 1974 – Swiss and Serbian
Member of the Nomination and Remuneration Committee
Barbara Angehrn is Chief Business Officer and Member of the Executive Committee at Vifor Pharma with responsibility for the Technical Operations, Manufacturing, IT and Corporate Communications functions.
Barbara joined Vifor Pharma in 2018 as Chief Business & Marketing Officer responsible for Global Commercial Functions as well as the overall Nephrology portfolio, until end of 2021.
Prior to Vifor Pharma Barbara was CEO and Founder of Stepstone Pharma and held Senior positions as Vice President Europe at Exelixis, Head of Commercial Operations at Onyx Pharmaceuticals (sold to Amgen for $10.5B) as well as Amgen International.
Barbara brings strong experience is several business areas: commercial operations, sales & marketing, pricing & reimbursement and business development. She has extensive international experience commercializing therapies in specialty pharma as well as working on early-stage pipeline programs in various therapeutic areas.
Barbara holds a bachelor’s degree in business administration and an MBA from the University St. Gallen.